Site and Treatment as fixed. [General Sta­tis­tics]

posted by ElMaestro  – Denmark, 2016-06-10 09:17 (3307 d 16:38 ago) – Posting: # 16426
Views: 6,933

Hi Dr Ripal,

❝ To be precise it is single dose two way cross over study of one of the taxanes and I am looking for the literature which supports evaluation of site effect and/or disease effect in bioequivalence studies.


Well, then it is a crossover and you need at least Site, Treatment, Sequence, Period, Subject in the model. Ideally Site has a high p-value.

❝ I have not come across literature of any patient based bioequivalence study which evaluates site effect as variable in statistical analysis.


Try harder. Google is your friend.

Pass or fail!
ElMaestro

Complete thread:

UA Flag
Activity
 Admin contact
23,425 posts in 4,928 threads, 1,682 registered users;
36 visitors (0 registered, 36 guests [including 12 identified bots]).
Forum time: 01:55 CEST (Europe/Vienna)

I think it is much more interesting to live with uncertainty
than to live with answers that might be wrong.    Richard Feynman

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5